Lexicon Genetics Incorporated has granted a non-exclusive sublicense to Biogen, Inc. for the use of certain aspects of Lexicon’s positive- negative selection technology for the generation of knockout mice. Biogen will use the technology in its internal drug-discovery and target validation programs. Financial terms were not disclosed. Lexicon‘s positive-negative selection technology is one of the Read more about Lexicon Sub-licenses Knockout Mouse Technology[…]